Evidence map›Paper›PMID 42251194›Full record

ArticleEMBO reports2026

The Legionella effector RidL binds the large fission GTPase Drp1 to promote mitochondrial fragmentation.

Ana Katic, Elizabeth Teresa Vittori, Stefanie Halter, Kevin Steiner, A Leoni Swart, Milad Radiom, Francisco Javier García-Rodríguez, Tobias Jäggi, Xiaodan Li, Jason A Mears and 4 more

Abstract read
In one paragraph

Article in EMBO reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors.

Ana Katic *Institute of Medical Microbiology, University of Zürich, Zürich, Switzerland.
Elizabeth Teresa Vittori *Institute of Medical Microbiology, University of Zürich, Zürich, Switzerland.ORCID 0009-0000-4466-5299
Stefanie HalterInstitute of Medical Microbiology, University of Zürich, Zürich, Switzerland.ORCID 0009-0008-0313-7965
Kevin SteinerInstitute of Medical Microbiology, University of Zürich, Zürich, Switzerland.
A Leoni SwartInstitute of Medical Microbiology, University of Zürich, Zürich, Switzerland.ORCID 0009-0001-7490-8199
Milad RadiomDepartment of Health Sciences and Technology, ETH Zürich, Zürich, Switzerland.ORCID 0000-0002-6339-9288
Francisco Javier García-RodríguezInstitut Pasteur, Université Paris Cité, CNRS UMR 6047, Paris, France.ORCID 0000-0001-9933-1990
Tobias JäggiInstitute of Medical Microbiology, University of Zürich, Zürich, Switzerland.ORCID 0009-0006-0547-2754
Xiaodan LiPaul Scherrer Institute, Villigen, Switzerland.ORCID 0000-0001-8647-7317
Jason A MearsCase Western Reserve University School of Medicine, Cleveland, OH, USA.ORCID 0000-0002-5199-4872
Carmen BuchrieserInstitut Pasteur, Université Paris Cité, CNRS UMR 6047, Paris, France.ORCID 0000-0003-3477-9190
Pedro EscollInstitut Pasteur, Université Paris Cité, CNRS UMR 6047, Paris, France.ORCID 0000-0002-5933-094X
Vikram Govind PanseInstitute of Medical Microbiology, University of Zürich, Zürich, Switzerland.ORCID 0000-0002-4770-7068
Hubert HilbiInstitute of Medical Microbiology, University of Zürich, Zürich, Switzerland. hilbi@imm.uzh.ch.ORCID 0000-0002-5462-9301

Funding

Agence Nationale de la Recherche (ANR) ANR-10-LABX-62-IBEIDAgence Nationale de la Recherche (ANR) ANR-21-CE15-0038-01Fondation pour la Recherche Medical EQU201903007847Institut Pasteur (Pasteur Institute) PTR; grant PTR-651-23Schweizerischer Nationalfonds zur Förderung der Wissenschaftlichen Forschung (SNF) 10.007.127Schweizerischer Nationalfonds zur Förderung der Wissenschaftlichen Forschung (SNF) 175557Schweizerischer Nationalfonds zur Förderung der Wissenschaftlichen Forschung (SNF) 207826
6 · The paper itself

Abstract

Intracellular pathogens such as Legionella pneumophila secrete effector proteins that manipulate host cell processes to promote bacterial survival. One such effector, RidL, is known to inhibit retrograde trafficking by interacting with the retromer complex via its N-terminal domain. Here, we identify a second function of RidL mediated by its C-terminal domain, which directly binds to the mitochondrial fission GTPase dynamin-related protein 1 (Drp1) and related large GTPases. In vitro, RidL reduces Drp1 GTPase activity and disrupts its oligomerization. During infection, RidL localizes to mitochondria, enhances the accumulation of Drp1 and the outer membrane protein Tom20, and impairs mitochondrial dynamics and function. Moreover, in L. pneumophila-infected cells, RidL promotes phosphorylation of Drp1 at Ser616, leading to Drp1 activation and mitochondrial fragmentation. These findings establish RidL as a bifunctional effector that targets both the retromer complex and Drp1 through distinct domains. By interfering with host mitochondrial dynamics, RidL enables L. pneumophila to remodel host organelles and optimize conditions for intracellular replication.

Indexed as

Bacterial ProteinsGTP PhosphohydrolasesLegionella pneumophilaMicrotubule-Associated ProteinsMitochondriaMitochondrial DynamicsMitochondrial ProteinsAnimalsDynaminsHost-Pathogen InteractionsHumansLegionnaires' DiseaseMitochondrial Membrane Transport ProteinsMitochondrial Precursor Protein Import Complex ProteinsPhosphorylationProtein BindingBacterial ProteinsDNM1L protein, humanDynaminsGTP PhosphohydrolasesMicrotubule-Associated ProteinsMitochondrial Membrane Transport ProteinsMitochondrial Precursor Protein Import Complex ProteinsMitochondrial Proteins

Identifiers

PMID42251194
PMCPMC13354802

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.